Comprehensive Laser Competitors

Kaiser Permanente's Division of Research (DOR) is one of the nation’s largest research facilities outside of a government or university setting. Our studies cover a wide range of clinical topics, including cardiovascular disease, cancer, diabetes, substance abuse, mental health, maternal and child health, and women’s health. Our research addresses broad issues, including the role of genes and the environment in health, the influence of behavior on disease prevention and chronic illness management, drug safety, health care policy, health services delivery, and disparities. The Division is currently home to 75 research scientists and staff scientists, 17 research fellows, and more than 674 employees. The DOR also has 46 adjunct investigators from within Kaiser Permanente Northern California (KPNC) and other academic institutions. DOR’s scientists are involved in 612 ongoing research projects and the KPNC Clinical Trials Program supports and guides 326 active clinical trials following 3,917 members. Since 2000, DOR researchers have published more than 8,100 peer-reviewed articles, and across all KPNC researchers there were more than 1,000 papers published in 2025 alone.

We're a leading global eye health organization that is dedicated to protecting and enhancing the gift of sight for millions of people around the world – from the moment of birth through every phase of life. Our comprehensive portfolio of more than 400 products includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products and ophthalmic surgical devices and instruments. Founded in 1853, we have a significant global research and development, manufacturing and commercial footprint with more than 12,000 employees and a presence in nearly 100 countries.

LasikPlus is proud to be a second generation family-owned and operated LASIK provider. Currently led by Craig P.R. Joffe and founded in 1995 by Dr. Stephen N. Joffe and his wife Sandra, our goal has always remained the same – to provide our patients with amazing care and customer service while offering industry-leading affordability. Collectively, the expert surgeons at LasikPlus have performed over 1.5 million procedures. We were one of the first providers to perform laser vision correction in the United States, shortly after the technology was approved by the Food and Drug Administration (FDA) in 1995. At LasikPlus, we use 100 percent bladeless technology and multiple laser platforms to ensure as many patients are candidates for laser vision correction as safely possible. And, multiple platforms allows us to customize treatment plan for each individual patients unique vision needs. We are always looking for experienced healthcare and other professionals to further strengthen our ability to provide our patients with world-class levels of customer satisfaction and service. What we do is only part of who we are. Our employees are the driving force behind our success.